Missing/wrong data?
Log in to edit
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis.
scientific article
Author/s
author: Jean-Yves Blay, Heikki Joensuu, Piotr Rutkowski, Sebastian Bauer
Work details
Publication date
November 6, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.